Memorial Sloan Kettering Cancer Center Update on the Treatment of Pituitary Tumors 2022

Description

+ Include: 17 videos + 14 pdfs, size: 5.48 GB

+ Target Audience: endocrinologists, neurosurgeons, otolaryngologists, radiation oncologists, neurologists, ophthalmologists, neuro-oncologists, family medicine and internal medicine physicians

+ Sample video: contact me for sample video

+ Information:

This didactic and case-based educational course will update attendees on the latest developments in ongoing basic and translational science as well as the clinical management of patients with pituitary conditions. This course aims to improve patient care and outcomes through evidence-based discussion of clinical practice guidelines and emerging therapies. Our goal is to assess and update current practices to promote earlier diagnosis and treatment of pituitary diseases. The multidisciplinary nature of the course will allow for the dissemination of knowledge across the variety of practitioners caring for patients with pituitary diseases, and for the patients themselves.

Provider/Clinical Track (Request for Case Submissions)

There will be a tumor board during the provider/clinical breakout session where attendees and faculty will review cases. Attendees will have an opportunity to submit a case for discussion during the course at registration. In order to prepare your submission, we ask that you provide a BRIEF summary of your case and include key lab results. Please ensure that all identifiable PHI has been removed. Cases should have an educational purpose. The course faculty will not be able to provide a detailed/complex consult review during the course and they will try to get through as many cases as possible.

Patient Track (Complimentary Registration for Patients)

We also invite patients with pituitary disease and their caregivers to attend this educational activity and participate in our interactive afternoon breakout sessions. Pituitary patients will be able to review treatment options, learn about ongoing clinical trials, and discuss their comprehensive care with providers and other patients. The educational objective of this patient session is to provide a forum for pituitary patients to discuss treatment options and new therapies with providers and other patients. Please note AMA PRA Category 1 Credits™ will not be offered for the patient breakout session. MSK is pleased to invite patients and caregivers to attend this course on a complimentary basis. If you are a patient or caregiver interested in attending, please email [email protected] to register (registration is required in order to attend).

Who Should Attend

This course is intended for endocrinologists, neurosurgeons, otolaryngologists, radiation oncologists, neurologists, ophthalmologists, neuro-oncologists, family medicine and internal medicine physicians, physicians in training and other allied health professionals who treat and manage patients with pituitary diseases. We also invite patients with pituitary disease and their caregivers to attend this educational activity and participate in our interactive afternoon breakout sessions.

1. Summarize ongoing clinical trials and emerging therapies for the treatment of Cushing’s and acromegaly
2. Discuss surgical outcomes, complications and risk management for pituitary and skull base tumors
3. Evaluate endoscopic surgery with the use of patient reported outcomes
4. Discuss integrative therapies and use of patient reported outcomes for pituitary patients
5. Present recent data on mechanisms and biomarkers for the development of aggressive and malignant pituitary tumors
6. Debate treatment decisions supporting the use and timing of new therapies for aggressive and malignant pituitary tumors
7. Review mechanisms, diagnosis and treatment of immunotherapy-induced hypophysitis

+ Topics:

Integrative Therapies and Use of Patient Reported Outcomes for Pituitary Patients.mp4
Integrative Therapies and Use of Patient Reported Outcomes for Pituitary Patients.pdf
Introduction and Welcome.mp4
Neurosurgical Complications and Expectations~1.mp4
New Therapies and Clinical Trials for Aggressive Pituitary Tumors.mp4
New Therapies and Clinical Trials for Aggressive Pituitary Tumors.pdf
New Therapies and Clinical Trials for Cushings.mp4
New Therapies and Clinical Trials for Cushings.pdf
Pathogenesis and Management of Aggressive Pituitary Tumors.mp4
Pathogenesis and Management of Aggressive Pituitary Tumors.pdf
Patient Caregiver Track- Nursing Talk for Patients on Comprehensive and Multidisciplinary Care.mp4
Patient Caregiver Track- Nursing Talk for Patients on Comprehensive and Multidisciplinary Care.pdf
Patient Caregiver Track- Rx Relax – Mindfulness in Supportive Pituitary Care.mp4
Patient Caregiver Track- Rx Relax – Mindfulness in Supportive Pituitary Care.pdf
Patient Caregiver Track- Tools for Coping with My Pituitary Diagnosis – A Psychotherapist’s Perspective.mp4
Patient Caregiver Track- Tools for Coping with My Pituitary Diagnosis – A Psychotherapist’s Perspective.pdf
Patient Reported Outcomes in Acromegaly.mp4
Patient Reported Outcomes in Acromegaly.pdf
Patient Track- Q&A with Faculty.mp4
Pituitary Published Articles.pdf
Pituitary2022_Brochure_v4.pdf
Provider Track- Clinical aspects and management of hypophysitis.pdf
Provider Track- Mechanisms of Immunotherapy-Induced Hypophysitis.mp4
Provider Track- Mechanisms of Immunotherapy-Induced Hypophysitis.pdf
Provider Track- Q&A with Faculty.mp4
Provider Track- Tumor Board.mp4
Provider Track- Tumor Board.pdf
Radiation Therapy Methods.mp4
Radiation Therapy Methods.pdf
Session I- Q&A with Faculty.mp4
Session II- Q&A with Faculty.mp4